{"id":"W3000484916","doi":"10.1177/1352458519898340","title":"World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies application","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Ocrelizumab; Alternative medicine; Public health; Family medicine; Disease; Nursing; Psychiatry; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0009245219,0.000592782,0.001004623,0.0005029507,0.00161901,0.0003599432,0.0005305097,0.0001278268,0.0006984993],"category_scores_gemma":[0.004483425,0.000513846,0.0003644412,0.002004409,0.0003796509,0.0005707979,0.0003103059,0.001055497,0.0001349425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004631967,"about_ca_system_score_gemma":0.0004954066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002263138,"about_ca_topic_score_gemma":0.0003224231,"domain_scores_codex":[0.9945085,0.0003901186,0.00130407,0.0009041541,0.001799013,0.001094116],"domain_scores_gemma":[0.9950058,0.0005710725,0.000725016,0.0005938515,0.00106292,0.00204132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001325599,0.0007652579,0.5954617,0.000661708,0.0006240489,0.00002227933,0.006800049,0.0005375202,0.2822953,0.00003186516,0.03248353,0.07899114],"study_design_scores_gemma":[0.01104752,0.0004248761,0.935625,0.001481392,0.0002240945,0.00003056887,0.001931416,0.0281638,0.01017215,0.00002712607,0.01016913,0.0007029318],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7062244,0.009217881,0.05995732,0.2182249,0.001093299,0.003791829,0.0002364397,0.001024148,0.0002297972],"genre_scores_gemma":[0.9783598,0.007119173,0.004450918,0.006623226,0.002883211,0.0001135974,0.0001978008,0.0001738705,0.00007844574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3401633,"threshold_uncertainty_score":0.9997313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1199043901657069,"score_gpt":0.3185671007195719,"score_spread":0.1986627105538651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}